Browsing "의과대학" byTitle

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 6421 to 6440 of 7912

Issue DateTitleAuthor(s)Type
2016Sensation seeking as a potential screening tool for suicidality in adolescence박혜숙; 이혜아Article
2007Sensitivity of polymerase chain reaction for pleural tuberculosis according to the amount of pleural effusion specimens문진욱Article
2006Sensitivity of polymerase chain reaction for pleural tuberculosis according to the amount of pleural effusion specimens장중현; 이진화; 문진욱; 류연주Meeting Abstract
2014Seoul criteria for PiB(-) subcortical vascular dementia based on clinical and MRI variables정지향Article
2009Separation of the Syncytial Layer of Spargana using Urea양현종Article
2004Septal fracture in simple nasal bone fracture박흥식; 강소라Article
2018Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma문영철Article
2007Sequential expression of NKCC2, TonEBP, aldose reductase, and urea transporter-A in developing mouse kidney한기환Article
2012Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.문영철Meeting Abstract
2011Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis문영철Meeting Abstract
2016Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial심기남Article
2008Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial성주명Meeting Abstract
2007Sequential VAD (vincristine, adriamycin, dexamethasone) and VTD (VELCADE (R), thalidomide, dexamethasone) induction followed by high-dose therapy with autologous stem cell transplantation and maintenance treatment with VELCADE for newly diagnosed multiple myeloma: Interim results of phase II trial성주명Meeting Abstract
2012Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: Results of a phase II trial성주명Article
2012Serial serum cholinesterase activities as a prognostic factor in organophosphate poisoned patients전영진; 최윤희Article
2011Seroepidemiology of hepatitis A in Korea: Changes over the past 30 years김경효Article
2013Seroepidemiology of varicella-zoster virus in Korea김경효Article
2012Seroprevalence of Helicobacter pylori in female Vietnamese immigrants to Korea이선영; 박혜숙; 박보현Article
2018Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016정혜경Article
2016Seroprevalence of Helicobacter pylori in Korea; multicenter, nationwide study in 2015정혜원Meeting Abstract

BROWSE